Related Experiment Videos

Subclinical hyperthyroidism and cardiovascular manifestations: a reevaluation of the association

Angelo Carpi1, Giuseppe Cini, Matteo Russo

  • 1Department of Clinical and Experimental Medicine, University of Pisa, Via Savi, 6-7, 56126, Pisa, Italy. angelo.carpi@med.unipi.it

Internal and Emergency Medicine
|March 7, 2013
PubMed

Insights

Subclinical hyperthyroidism (SH) is linked to cardiovascular issues, but atrial fibrillation (AF) isn't the main connection. Early atherosclerosis, indicated by carotid artery changes, may explain SH's impact on heart health.

Area of Science:

  • Endocrinology
  • Cardiology
  • Vascular Biology

Background:

  • Subclinical hyperthyroidism (SH) is associated with increased risks of atrial fibrillation (AF), heart failure (HF), and coronary heart disease (CHD).
  • Expert opinion suggests AF may be the primary mediator linking SH to other cardiovascular (CV) manifestations.

Purpose of the Study:

  • To investigate the relationship between SH and major cardiovascular events, specifically examining the role of AF as a potential link.
  • To explore alternative mechanisms, such as early atherosclerosis, that may connect SH to cardiovascular disease.

Main Methods:

  • Analysis of data from three recent studies encompassing 60,883 participants, including 2,284 individuals with SH.
  • Comparison of the ratio of AF events to other cardiovascular events in SH patients versus euthyroid (ET) individuals.

Main Results:

  • The ratio of AF events to other CV events was not significantly higher in SH patients compared to ET individuals across six comparisons.
  • This finding suggests that AF is unlikely to be the predominant link between SH and associated cardiovascular manifestations.

Conclusions:

  • Atrial fibrillation does not appear to be the major link between subclinical hyperthyroidism and cardiovascular events.
  • Increased prevalence of early atherosclerosis, evidenced by carotid intima media thickness and integrated back scatter, is proposed as a significant contributing factor linking SH to cardiovascular manifestations.

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...